A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2020-02-18
Target enrollment:
Participant gender:
Summary
The reason for this study is to see if the study drug LY3209590 is safe and effective in
participants with type 2 diabetes that have already been treated with basal insulin.